In a recent development, a U.S. appeals court has upheld the decisions made by the International Trade Commission (ITC) in the long-standing patent dispute between tech giant Apple and medical technology company Masimo. The ruling reaffirms the initial findings by the ITC, reinforcing Masimo's claims of patent infringement by Apple relating to health monitoring features in their Apple Watch.
The dispute began back in 2019 when Masimo filed a complaint with the ITC, accusing Apple of stealing its patented technology for non-invasive blood oxygen monitoring. Masimo's technology, known as Signal Extraction Technology (SET), utilizes sensors to measure various physiological parameters, including oxygen levels in the blood.
